BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory

MAbSilico

MAbSilico is a deeptech company from French academic research labs. Founded in 2017, MAbSilico is a software editor with the vision to accelerate the development of therapeutic antibody focusing on the early stage development to provide leads in a few years today to a few weeks.

MAbSilico is developing a software suite combining algorithms and databases based on 20 years of proven research and protected by patent. Our Artificial Intelligence and machine learning -driven tools cover two key steps of the early-stage antibody development; the lead identification and the lead characterization.

therapeutic antibody protein interaction target identification